News | Qiming Venture Partners USA

February 08, 2021

Jasper’s cell therapy conditioning agent shows promise in small study

Portfolio Company

January 28, 2021

Cardialen awarded US$2.8 million grant for study of low-energy cardioversion in AF

Portfolio Company

January 27, 2021

Auron Therapeutics Closes $12.75 Million Seed Financing to Develop Differentiation Therapies for Treatment of Cancers

Portfolio Company

January 20, 2021

Talaris Therapeutics Adds Two Experienced Biotechnology Executives to its Board of Directors

Portfolio Company

January 13, 2021

Jasper Therapeutics and Graphite Bio Announce Collaboration to Evaluate JSP191 as Conditioning Regimen for Novel Gene Replacement Therapy in Patients with XSCID

Portfolio Company

January 09, 2021

Korro Bio to Present at J.P. Morgan Healthcare Conference

Portfolio Company

Load More